Specifically, Trifirò et al. found that, in a general population of Southern Italy, the treatment of DM among CKD patients changed only marginally after the diagnosis of CKD, with a slight reduction of metformin use and an increase in the use of insulin and repaglinide [7]. This evidence concerns the gene INS and diabetes mellitus.